Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 151 M172 M174 M172 M162 M176 M 684 M Research & development —————— — Operating income 153 M274 M270 M129 M166 M297 M 862 M Non-Operating Income, Total 6 M4 M6 M6 M5 M5 M 22 M Interest expense, net of interest capitalized 19 M20 M20 M20 M19 M19 M 78 M Non-Operating Income, excl. Interest Expenses -13 M-16 M-14 M-14 M-14 M-14 M -56 M Unusual income/expense —————— — Pretax income 48 M146 M142 M2 M51 M167 M 362 M Equity in earnings —————— — Taxes 11 M36 M37 M010 M41 M 88 M Non-controlling/minority interest —————— — After tax other income/expense -1 M-3 M1 M2 M2 M1 M 6 M Net income before discontinued operations 37 M111 M106 M1 M41 M125 M 273 M Discontinued operations —————— — Net income 37 M111 M106 M1 M41 M125 M 273 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 37 M111 M106 M1 M41 M125 M 273 M Basic earnings per share (Basic EPS) 0.51.511.450.020.581.8 3.85 Diluted earnings per share (Diluted EPS) 0.491.481.420.030.571.76 3.78 Average basic shares outstanding 74.7 M73.5 M72.8 M73.1 M70.6 M69.9 M — Diluted shares outstanding 76.3 M74.7 M74.4 M74.5 M72.2 M71.1 M — EBITDA 166 M286 M284 M181 M178 M309 M 952 M EBIT 153 M274 M271 M128 M166 M297 M 862 M Cost of revenue 191 M261 M264 M220 M203 M267 M 954 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 13 M12 M13 M53 M12 M12 M 90 M